JSPR
Jasper Therapeutics
$0.53
−$0.01 (−1.3%)Oct 29, 2026
Key metrics
The numbers that frame JSPR today
- Market cap
- $17.70M
- ROIC
- 538.5%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $0.32
- 52wk High
- $2.51
Growth
Revenue and earnings trend for JSPR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about JSPR
Is Jasper Therapeutics a good buy?
No. Jasper Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Jasper Therapeutics is selling at a very high price.
What is the market capitalization of JSPR?
Jasper Therapeutics's market capitalization is $17.70M.
What is the 52-week high for JSPR stock?
The 52-week high for Jasper Therapeutics is $2.51. The current close of $0.53 is 78.8% below that high.
What is the 52-week low for JSPR stock?
The 52-week low for Jasper Therapeutics is $0.32. The current close of $0.53 is 68.9% above that low.
Does JSPR stock pay dividends?
Jasper Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for JSPR?
Jasper Therapeutics's Debt / Equity ratio is 0.19.